Article Details

FDA Approves GSK's Checkpoint Inhibitor Jemperli for Endometrial Cancer

Retrieved on: 2021-04-22 19:07:30

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves GSK's Checkpoint Inhibitor Jemperli for Endometrial Cancer. View article details on hiswai:

Excerpt

The active component is dostarlimab, an antineoplastic monoclonal antibody that improves T-cell responses, including anti-tumor responses via ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up